Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07025915

A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males

A Mass Balance Study of [14C]SSS17 in Healthy Chinese Male Subjects

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
6 (estimated)
Sponsor
Shenyang Sunshine Pharmaceutical Co., LTD. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate the absorption, metabolism, and excretion of a single oral dose of \[¹⁴C\]SSS17 in healthy adult Chinese male subjects, elucidating its overall pharmacokinetic profile in humans to provide essential information for its rational clinical use.

Conditions

Interventions

TypeNameDescription
DRUG[14C]SSS17single oral dose

Timeline

Start date
2025-06-01
Primary completion
2025-07-01
Completion
2025-07-01
First posted
2025-06-18
Last updated
2025-06-25

Source: ClinicalTrials.gov record NCT07025915. Inclusion in this directory is not an endorsement.